FDA Inspection 1162565 — WES Pharma Inc.
The FDA completed an inspection of WES Pharma Inc. on February 18, 2022 in Westminster, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 18, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Westminster, MD (United States)